New technique improves T cell-based immunotherapies for solid tumors (IMAGE)

Scripps Research Institute

New technique improves T cell-based immunotherapies for solid tumors

Caption

The Scripps Research team fused the enzyme sialidase onto bispecific T-cell engager (BiTE) molecules, helping break down the cancer cells’ outer barriers and thereby activating T cells against the cancer.

Credit

Scripps Research

Usage Restrictions

Can be used with related coverage and with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.